Abstract:OBJECTIVETo investigate the expression of integrin beta3 and osteopontin (OPN) in eutopic and ectopic endometrium of adenomyosis.METHODSFrom January 2007 to July 2008, the endometrium specimens were collected from 43 patients with adenomyosis undergoing hysterectomy in Peking University First Hospital. Eutopic endometrium were 11 in proliferative phase and 32 in secretory phase (18 cases in mid-secretory phase) were collected. Ectopic endometriums were also collected. In the mean time, it was chosen 41 cases with pure subserous uterine myoma or cervical intraepithelial neoplasia (CIN) II-III treated by hysterectomy as controls including 12 endometrium in proliferative phase and 29 endometrium in secretory phase (19 cases in mid-secretory phase). The expression of Integrin beta3 subunit and OPN in the endometrium were assessed by immunohistochemical staining and quantitative real-time polymerase chain reaction.RESULTS(1) Immunohistochemical staining showed that positive staining of integrin beta3 and OPN were present predominantly in eutopic and ectopic endometrial glandular epithelium. There was significant different protein expression of integrin beta3 and OPN, which were 1.6 +/- 0.8 and 1.7 +/- 0.7 in eutopic endometrium, 1.7 +/- 0.7 and 1.8 +/- 0.9 in ectopic endometrium, 2.1 +/- 0.9 and 2.0 +/- 0.9 in control endometrium (P < 0.05). The protein expression of integrin beta3 and OPN in eutopic endometrium of adenomyosis in the proliferative phase (0.8 +/- 0.4 and 0.7 +/- 0.3) were remarkably lower than those of the secretory phase (1.8 +/- 0.8 and 1.9 +/- 0.8, P < 0.01). The protein expression of integrin beta3 and OPN in the endometrium of controls in the proliferative phase (1.0 +/- 0.4 and 1.0 +/- 0.4) were significantly lower than those of the secretory phase (2.5 +/- 0.7 and 2.5 +/- 0.7) (P = 0.000). In the mid-secretory phase, the protein expression of integrin beta3 (2.0 +/- 0.9) and OPN (2.1 +/- 0.8) in eutopic endometrium of adenomyosis were significantly lower than that of control endometrium (2.7 +/- 0.5 and 2.7 +/- 0.7) (P < 0.01). (2) The mRNA expression level of integrin beta and OPN in eutopic and ectopic endometrium were assessed by quantitative real-time PCR (result was shown by median index). It was observed that integrin beta3 mRNA and OPN mRNA were significantly lower in the eutopic endometrium of adenomyosis (4.69 and 4.23), when compared with ectopic endometrium (7.96 and 14.84) and controls (13.47 and 17.40) (P < 0.05). Eutopic endometrium had higher mRNA expression of integrin beta and OPN mRNA in the secretory phase (5.54 and 11.40) than that in the proliferative phase (2.69 and 3.30) (P < 0.01). The mRNA expression level of integrin beta and OPN of control endometrium in the proliferative phase (3.12 and 4.75) were significantly lower than that in the secretory phase (19.94 and 21.00, P = 0.000). The mRNA expression of integrin beta and OPN were 10.10 and 14.34 in the mid-secretory phase, which were significantly lower than 21.50 and 24.18 in control endometrium (P < 0.05).CONCLUSIONSHigh expression of integrin beta3 and OPN in ectopic endometrium of adenomyosis may cause endometriotic lesions; abnormal expression of integrin beta3 and OPN in the endometrium of adenomyosis during the implantation window may contribute to infertility in some patients.

Expression of osteopontin in human endometrium throughout menstrual cycle

Expression of osteopontin in mouse oviduct during the estrous cycle and early pregnancy

Osteopontin Regulates Endometrial Stromal Cell Migration in Endometriosis Through the PI3K Pathway

Calcium-binding protein S100P is highly expressed during the implantation window in human endometrium.

Expression of osteopontin in endometrial carcinoma and cervical cancer

Expression of Endometrial Osteopontin Mrna and Its Correlation with Unexplained Infertility

Osteopontin is expressed in the oviduct and promotes fertilization and preimplantation embryo development of mouse.

ORIGINAL ARTICLE: Modulation of Expression of Toll‐like Receptors in the Human Endometrium

Expression and Regulation of Osteopontin in Ishikawa Cell Line

Osteopontin And Integrin Alpha V Beta 3 Expression During The Implantation Window In Ivf Patients With Elevated Serum Progesterone And Oestradiol Level

[Expression of Integrin Beta3 and Osteopontin in Endometrium of Patients with Adenomyosis].

[Expression of Osteopontin Mrna in Oral Squamous Cell Carcinoma and Normal Oral Mucosa].

Expression of Integrin Β3 and Osteopontin in the Eutopic Endometrium of Adenomyosis During the Implantation Window.

The expression of osteopontin(OPN) in ovarian tumors and its association with malignancy

The expression of leptin and leptin receptor in the human endometriumduring the normal menstrual cycle

Uterine Micro-Environment and Estrogen-Dependent Regulation of Osteopontin Expression in Mouse Blastocyst

Expression and Significance of Kiss-1 and Osteopontin in Ectopic and Eutopic Endometrium in Patients with Endometriosis

Expression Of Osteopontin In Human Decidua: Its Role In Decidual Recruitment Of Natural Killer Cells

[Expression of Osteopontin Mrna and Its Protein in Colorectal Cancer and Liver Metastatic Tissues].

Expression and clinical significance of osteopontin in gastric cancer

Differential Expression of HOXA11 in Human Endometrial Glandular Epithelial and Stromal Cells